Results 181 to 190 of about 141,283 (272)

JAK-1 inhibitors in the management of atopic dermatitis in patients over 65 years old: a descriptive cohort study. [PDF]

Sci Rep
Zheng J, Robles-Velasco K, Sharma S, de Souza Lima ICA, Pasquini VF, Ducati RG, Lima H.   +6 more
europepmc   +1 more source

Stratum Corneum Ceramide Abnormalities in Atopic Dermatitis: Pathophysiology and Implications for Disease Management

The Journal of Dermatology, EarlyView.
ABSTRACT The stratum corneum, as the outermost layer of the skin, functions as a critical barrier that maintains cutaneous hydration and systemic homeostasis. Among its structural lipids, ceramides constitute the most abundant and diverse component. These molecules are essential for the formation of lamellar structures that secure barrier integrity ...
Takashi Sakai
wiley   +1 more source

Development and Validation of the Japanese Version of the Hyperhidrosis Quality of Life Index

The Journal of Dermatology, EarlyView.
ABSTRACT Hyperhidrosis decreases an individual's quality of life (QOL). The Hyperhidrosis Quality of Life Index (HidroQoL) measures the impact of hyperhidrosis on QOL and has established reliability and validity. However, a Japanese version does not exist.
Sayaka Ogawa, Jun Tayama, Paul Kamudoni, Sam Salek, Peter Bernick, Masakazu Kobayashi, Seiko Nakamichi, Hiroyuki Murota   +7 more
wiley   +1 more source

Efficacy of Polynucleotide-Based Therapy in Atopic Dermatitis Management. [PDF]

J Cosmet Dermatol
Bae K, Cho Y, Soo K, Lee J, Park Y, Hyun Y, Kim JH, Yi K.   +7 more
europepmc   +1 more source

Treatment Patterns and Healthcare Utilization on Pediatric Atopic Dermatitis With Allergic Comorbidities: A Japanese Claims‐Based Study

The Journal of Dermatology, EarlyView.
ABSTRACT Atopic dermatitis (AD) is a chronic, itchy skin disease that often begins in infancy and may persist into adulthood. The high co‐occurrence of allergic comorbidities (ACMs; asthma, food allergy, and allergic rhinitis) makes it a growing public health concern.
Masaki Futamura, Yumi Kang, Ambrish Singh, Junichi Danjo, Takashi Matsuo, Hitoe Torisu‐Itakura, Mizuho Nagao   +6 more
wiley   +1 more source

Eczematous molluscum contagiosum masquerading as herpes simplex in an 8-year-old: A case report. [PDF]

SAGE Open Med Case Rep
Atique A, Kanou M, Leclerc N, Chow W, Xie C, Litvinov IV.   +5 more
europepmc   +1 more source

Safety Evaluation of Fine Bubble Shower Washing for Patients With Atopic Dermatitis: A Double‐Blind, Randomized, Prospective Crossover Clinical Trial

The Journal of Dermatology, EarlyView.
ABSTRACT Atopic dermatitis (AD) involves chronic eczema resulting from barrier dysfunction. Fine bubble (FB) technology generates microbubbles (< 100 μm) and ultrafine bubbles (< 1 μm) for surfactant‐sparing cleansing. We assessed the short‐term safety of an FB shower in AD.
Hiroshi Kato, Risa Tamagawa‐Mineoka, Eiji Nakatani, Kenichi Yoshimura, Yukiko Yasui, Kasumi Kato, Motoki Nakamura, Ako Kurachi, Soshi Takeda, Akimichi Morita   +9 more
wiley   +1 more source

Distribution of Allergy Diagnoses and Cardiometabolic Comorbidities Among Older Adults with EHR-Recorded Allergic Diseases - A Single-Center Retrospective Study. [PDF]

J Asthma Allergy
Formaker P, Espinoza L, Jain L, Kieu C, Dabu J.   +4 more
europepmc   +1 more source

Long‐Term, Site‐Specific Effectiveness of Tralokinumab in Atopic Dermatitis: A 72‐Week Real‐World Study

The Journal of Dermatology, EarlyView.
ABSTRACT Tralokinumab, an anti‐IL‐13 antibody, is effective for atopic dermatitis (AD); however, its long‐term (> 1 year) effectiveness specific to each anatomical site is unknown in real‐world settings. To evaluate 72‐week effectiveness of tralokinumab on different anatomical sites in AD, we studied 208 patients with moderate‐to‐severe AD treated with
Mizuki Shiba, Teppei Hagino, Akihiko Uchiyama, Hidehisa Saeki, Eita Fujimoto, Sei‐ichiro Motegi, Naoko Kanda   +6 more
wiley   +1 more source

Unravelling the Mystery of Psoriasis Dermatitis (PsoDermatitis): A Practical Guide to Recognition and Management. [PDF]

J Clin Med
Balestri R, Magnano M, Infusino SD, Ioris T, Lacava R, Girardelli CR, Rech G.   +6 more
europepmc   +1 more source